Prof Tim Lambert

Tim Lambert is Professor of Psychiatry at Concord Clinical School at The University of Sydney in Australia. He also holds an appointment as Head of Schizophrenia Treatment and Outcomes Research at the Brain & Mind Research Institute in Sydney. In addition, he fulfils clinical duties for the SSWAHS in Sydney as Director of the Centre of Excellence in Relapse Prevention in Psychosis (CERP), and at the Concord Centre for Cardiometabolic Health in Psychosis (ccCHIP).

Professor Lambert has a portfolio of interests spanning clinical psychosis research, outcomes research, training, and education. His current interests focus on services research (pharmacoepidemiology); the clinical pharmacology of LAI antipsychotics (first and second generation) and of the second and generation antipsychotics, particularly risk-benefit aspects and the applied clinical pharmacology of antipsychotic switching; physical comorbidities of psychotic disorders, especially metabolic syndrome; and incomplete recovery. His work has been utilised to produce educational and training materials, including CD-ROMs and DVDs, for mental health workers in many parts of the world.

He has been a principal in the development of a number of clinical practice guidelines, algorithms, and consensus documents. Currently, he is chairing the consensus development group for treatment resistant schizophrenia. Professor Lambert is a regularly invited lecturer, clinical trainer, and industry consultant throughout Asia, Australia, Europe, and North America.

He is a member of a number of international and national advisory groups concerned with antipsychotic treatments.